oseltamivir has been researched along with Obesity in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (86.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cavallazzi, R; DeLapp, DA; Furmanek, S; Glick, C; Ramirez, JA | 1 |
| Baeza-Flores, GDC; Denis-García, CA; Flores-Barrientos, OI; Gonzalez-Castro, TB; Guzmán-Priego, CG; Juárez-Rojop, IE; López-Brito, CR; Narváez-Osorio, V; Nolasco-Rosales, GA; Pérez-García, A; Ruíz-Quiñonez, JA; Tovilla-Zarate, CA | 1 |
| Chong, CY; Fu, S; Menon, A; Tan, NW; Tee, NW; Thoon, KC | 1 |
| Charunwattana, P; Day, NP; Hanpithakpong, W; Jittamala, P; Lawpoolsri, S; Lindegardh, N; Panapipat, S; Pukrittayakamee, S; Tarning, J; Taylor, WR; White, NJ | 1 |
| Biondi, E | 1 |
| Chairat, K; Day, NP; Hanpithakpong, W; Jittamala, P; Pukrittayakamee, S; Tarning, J; White, NJ | 1 |
| Barranco-Garduño, LM; Carrasco-Portugal, Mdel C; Castañeda-Hernández, G; Cervantes-Nevárez, A; Flores-Murrieta, FJ; León-Molina, H; Martínez-Talavera, A | 1 |
| Battegay, M; Daneschwar, F; Tschudin Sutter, S; Widmer, AF | 1 |
| Chan, KH; Hung, IF; Li, IW; To, KK; Tse, H; Wong, SS; Woo, PC; Yuen, KY | 1 |
| Campins, A; Carratalà, J; Fariñas, MC; Gudiol, F; López-Medrano, F; Martínez-Montauti, J; Moreno, A; Oteo, JA; Pachón, J; Paño-Pardo, JR; Rodríguez-Baño, J; Segura, F; Torre-Cisneros, J; Viasus, D; Villoslada, A | 1 |
| Feng, L; Feng, Y; Feng, Z; Gao, Z; Gargiullo, P; Huai, Y; Jiang, H; Liao, Q; Peng, Z; Shu, Y; Uyeki, TM; Wang, Y; Xiang, N; Xu, C; Yang, W; Ye, M; Yu, H; Yuan, Y; Zhang, Y; Zheng, J; Zheng, Y; Zhou, L | 1 |
| Lodise, TP; Pai, MP | 1 |
| Beck, MA | 1 |
| Duan, S; Govorkova, EA; McCullers, JA; O'Brien, KB; Schultz-Cherry, S; Vogel, P; Webby, RJ | 1 |
| Barquilla, E; Iribarren, JA; Knobel, H; López-Aldeguer, J; Lozano, F; Santos, J; Valencia, E | 1 |
1 review(s) available for oseltamivir and Obesity
| Article | Year |
|---|---|
It doesn't have to be EviDense.
Topics: Adult; Anticoagulants; Antiviral Agents; Child; Evidence-Based Medicine; Humans; Influenza, Human; Integrative Medicine; International Normalized Ratio; Obesity; Oseltamivir; Pain Management; Warfarin | 2014 |
4 trial(s) available for oseltamivir and Obesity
| Article | Year |
|---|---|
Patients with Obesity Have Better Long-Term Outcomes after Hospitalization for COPD Exacerbation.
Topics: Aged; Antiviral Agents; Body Mass Index; Disease Progression; Female; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Obesity; Oseltamivir; Pulmonary Disease, Chronic Obstructive | 2020 |
Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
Topics: Administration, Oral; Adult; Antiviral Agents; Body Mass Index; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Obesity; Oseltamivir; Thailand; Young Adult | 2014 |
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers.
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Models, Biological; Obesity; Oseltamivir; Volunteers; Young Adult | 2016 |
Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.
Topics: Adult; Antiviral Agents; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Obesity; Oseltamivir; Treatment Outcome; Young Adult | 2011 |
10 other study(ies) available for oseltamivir and Obesity
| Article | Year |
|---|---|
Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 1; Female; Hospital Mortality; Hospitals; Humans; Hydroxychloroquine; Length of Stay; Male; Mexico; Middle Aged; Obesity; Oseltamivir; Retrospective Studies; SARS-CoV-2; Sex Factors | 2021 |
Risk Factors for Complicated Influenza A (H1N1) 2009 Disease in Children.
Topics: Adolescent; Age Factors; Antiviral Agents; Asthma; Bronchitis; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fluid Therapy; Gastritis; Gastroenteritis; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Obesity; Oseltamivir; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Seizures; Singapore | 2013 |
Oseltamivir pharmacokinetics in Mexican obese and non-obese healthy subjects and patients. Evidence for an absence of interethnic variability.
Topics: Antiviral Agents; Healthy Volunteers; Humans; Mexico; Obesity; Oseltamivir | 2016 |
[42-year-old obese man with H1N1 influenza A infection necessitating mechanical ventilation].
Topics: Adult; Antiviral Agents; Bronchopneumonia; Critical Care; Diagnosis, Differential; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Obesity; Oseltamivir; Positive-Pressure Respiration; Respiratory Distress Syndrome; Tomography, X-Ray Computed | 2010 |
Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Obesity; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Seasons; Treatment Outcome; Young Adult | 2010 |
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bacterial Infections; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Obesity; Oseltamivir; Pandemics; Pneumonia; Prospective Studies; Risk Factors; Severity of Illness Index; Spain; Treatment Outcome | 2011 |
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; China; Chronic Disease; Female; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Obesity; Oseltamivir; Pregnancy; Risk Factors; Young Adult | 2011 |
Influenza and obesity: will vaccines and antivirals protect?
Topics: Animals; Antibodies, Viral; Antiviral Agents; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Lung; Male; Obesity; Orthomyxoviridae Infections; Oseltamivir | 2012 |
Impaired wound healing predisposes obese mice to severe influenza virus infection.
Topics: Albumins; Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Kaplan-Meier Estimate; Ki-67 Antigen; Leukocyte Count; Lung; Male; Mice; Mice, Inbred C57BL; Models, Animal; Monocytes; Neutrophil Infiltration; Obesity; Orthomyxoviridae Infections; Oseltamivir; Pulmonary Edema; Severity of Illness Index; Viral Load; Wound Healing | 2012 |
Outcomes in HIV-infected patients admitted due to pandemic influenza.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Comorbidity; Female; HIV Infections; Hospital Mortality; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Inpatients; Intensive Care Units; Length of Stay; Male; Middle Aged; Obesity; Oseltamivir; Pandemics; Respiratory Tract Diseases; Sepsis; Smoking; Spain; Symptom Assessment; Treatment Outcome; Vaccination | 2012 |